Temozolomide and Thalidomide in Treating Patients With Brain Metastases Secondary to Melanoma

Clinical trial NCT00072163 · COMPLETED

Trial details

NCT number: NCT00072163
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Melanoma Stage IV Melanoma Tumors Metastatic to Brain

Start date: 2003-10-01
Primary completion: 2006-09-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.